The kidney reabsorption-related magnesium depletion score is associated with cardiovascular disease and longitudinal mortality in diabetic kidney disease patients

被引:1
|
作者
Zhou, Zhengxi [1 ]
Yao, Xiaotian [1 ,2 ,3 ]
机构
[1] Ningbo Mingzhou Hosp, Dept Urol, Ningbo, Zhejiang, Peoples R China
[2] Sun Yat sen Univ, Affiliated Hosp 6, Div Nephrol, Guangzhou, Guangdong, Peoples R China
[3] Sun Yat sen Univ, Affiliated Hosp 6, Biomed Innovat Ctr, Guangzhou, Guangdong, Peoples R China
关键词
MDS; Magnesium depletion score; DKD; Mortality; CVD; SERUM MAGNESIUM; HYPOMAGNESEMIA; REQUIREMENTS; PREVENTION; EXCRETION; UPDATE;
D O I
10.1186/s13098-025-01598-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The kidney reabsorption is essential for maintaining magnesium homeostasis. This study aims to explore the relationship between kidney reabsorption-related magnesium depletion score (MDS) and the occurrence of cardiovascular disease (CVD) and prognosis in diabetic disease kidney (DKD) patients. Methods We included 3199 DKD patients from the National Health and Nutrition Examination Survey (NHANES) database, including 1072 CVD patients. Weighted logistic regression analysis was used to explore the relationship between MDS and the occurrence of CVD. Weighted COX proportional hazards regression was used to explore the relationship between MDS and mortality. Stratified analysis was used to further validate. Finally, we assessed the predictive accuracy of MDS on survival outcomes in DKD patients using time-dependent receiver operating characteristic (ROC) curve analysis. Results Survey-weighted multiple logistic regression analysis revealed that MDS >= 3, the incidence of CVD increased by 371%. During the follow-up period (median of 87 months), 1373 all-cause deaths (497 cardiovascular deaths) were recorded. In DKD patients, MDS >= 3, all-cause mortality increased 78% (P < 0.001) and cardiac mortality 76% (P = 0.08). Consistent results were also shown when stratified by age, sex, race, marital status, magnesium intake. The area under the curve (AUC) values for predicting 1-,2-,3-,4-, and 5-year mortality using MDS were 0.86, 0.66, 0.59, 0.57, and 0.55, for all-cause mortality and 0.9, 0.67, 0.62, 0.58, and 0.56 for cardiovascular mortality. Conclusion MDS, kidney reabsorption-related, is positively correlated with the incidence of CVD and longitudinal mortality in DKD patients.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Urea levels and cardiovascular disease in patients with chronic kidney disease
    Laville, Solene M.
    Couturier, Aymeric
    Lambert, Oriane
    Metzger, Marie
    Mansencal, Nicolas
    Jacquelinet, Christian
    Laville, Maurice
    Frimat, Luc
    Fouque, Denis
    Combe, Christian
    Robinson, Bruce M.
    Stengel, Benedicte
    Liabeuf, Sophie
    Massy, Ziad A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (01) : 184 - 192
  • [32] Muscle relaxant use and the associated risk of incident frailty in patients with diabetic kidney disease: a longitudinal cohort study
    Lee, Szu-Ying
    Wang, Jui
    Tsai, Hung-Bin
    Chao, Chia-Ter
    Chien, Kuo-Liong
    Huang, Jenq-Wen
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2021, 12
  • [33] Race, Biomarkers, and Cardiovascular Disease in Patients With Chronic Kidney Disease
    Nicholas, Susanne B.
    Norris, Keith C.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (18):
  • [34] Glycosuria amount in response to hyperglycaemia and risk for diabetic kidney disease and related events in Type 1 diabetic patients
    Carpentier, Charlyne
    Dubois, Severine
    Mohammedi, Kamel
    Belhatem, Narimene
    Bouhanick, Beatrice
    Rohmer, Vincent
    Briet, Claire
    Bumbu, Anisoara
    Hadjadj, Samy
    Roussel, Ronan
    Potier, Louis
    Velho, Gilberto
    Marre, Michel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (10) : 1731 - 1738
  • [35] Associations between the serum magnesium and all-cause or cardiovascular mortality in chronic kidney disease and end-stage renal disease patients A meta-analysis
    Liu, Hongyan
    Wang, Rui
    MEDICINE, 2021, 100 (45) : E27486
  • [36] Association between the coexistence of chronic kidney disease and sarcopenia with cardiovascular disease and mortality
    Jiang, Lijun
    Xu, Liangliang
    Sun, Wen
    Bian, Keyu
    Wang, Yuan
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2025, 37 (01)
  • [37] The effects of chronic kidney disease stages on dyslipidemia, cardiovascular disease prevalence and mortality
    Hoca, Emre
    Mermer, Huseyin Bulent
    Kula, Atay Can
    Ahbab, Suleyman
    Ataoglu, Hayriye Esra
    NORTHERN CLINICS OF ISTANBUL, 2025, 12 (01) : 95 - 102
  • [38] Association between Kidney Function and Framingham Global Cardiovascular Disease Risk Score: A Chinese Longitudinal Study
    Jin, Bo
    Bai, Xiaojuan
    Han, Lulu
    Liu, Jing
    Zhang, Weiguang
    Chen, Xiangmei
    PLOS ONE, 2014, 9 (01):
  • [39] Kidney Function and Risk of Cardiovascular Disease and Mortality in Kidney Transplant Recipients: The FAVORIT Trial
    Weiner, D. E.
    Carpenter, M. A.
    Levy, A. S.
    Ivanova, A.
    Cole, E. H.
    Hunsicker, L.
    Kasiske, B. L.
    Kim, S. J.
    Kusek, J. W.
    Bostom, A. G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (09) : 2437 - 2445
  • [40] Diabetic kidney disease versus non-diabetic kidney disease in type 2 diabetic patients on dialysis: An observational cohort
    Delautre, Arnaud
    Hannedouche, Thierry
    Couchoud, Cecile
    Guiserix, Jose
    Cerasuolo, Damiano
    Chantrel, Francois
    Martzloff, Jonas
    Keller, Nicolas
    Krummel, Thierry
    ENDOCRINOLOGY DIABETES & METABOLISM, 2022, 5 (04)